Metastatic Breast Cancer
Advisory Board
Fatima Cardoso, MD, FESMO
Director, Breast Unit, Champalimaud Clinical Centre, Lisbon, Portugal; President, ABC Global Alliance
Dr Cardoso is board certified in medical oncology and internal medicine. In 2010, she created the Breast Unit of the Champalimaud Clinical Centre in Lisbon, Portugal. Her research interests include biology of breast cancer, prognostic and predictive markers of response to systemic therapy, and new anticancer agents. Dr Cardoso is actively involved in many phase 1-4 breast cancer clinical trials, and she has won many awards for her involvement in breast cancer research, including the Order of Santiago da Espada for Scientific Merit from the President of Portugal.
Dr Cardoso is deeply involved in the field of cancer policy, accessibility, and inequalities and is the founder and president of the Advanced Breast Cancer (ABC) Global Alliance as well as the founder and chair of the ABC International Consensus Conference and Guidelines.
Dr Cardoso is active in numerous professional organizations, where she serves on several committees. She is editor-in-chief of The Breast Journal, associate editor of the European Journal of Cancer, and an editorial board member of several other journals.
Dr Cardoso has authored about 350 publications and has presented her work nationally and internationally.
Hope S. Rugo, MD, FASCO
Winterhof Family Endowed Professorship in Breast Cancer; Professor, Department of Medicine, Division of Hematology and Oncology, UCSF School of Medicine; Director, Breast Oncology and Clinical Trials Education; Medical Director, Cancer Infusion Services, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California
Dr Rugo is a professor of medicine in the Division of Hematology and Oncology at the University of California, San Fransisco (UCSF) School of Medicine. She is director of Breast Oncology and Clinical Trials Education at UCSF Helen Diller Family Comprehensive Cancer Center. Dr Rugo is an internationally recognized expert in breast cancer. Her research interests include novel therapies for advanced breast cancer, immune modulation to restore chemotherapy sensitivity, evaluation of circulating tumor DNA as a marker of response and resistance to therapy, neoadjuvant therapy, and safety/supportive care.
Dr Rugo is a principal investigator of multiple clinical trials and has published widely in medical journals. Dr Rugo also plays an active role in the Alliance for Clinical Trials in Oncology, the Translational Breast Cancer Research Consortium, American Society of Clinical Oncology, Multinational Association of Supportive Care in Cancer, and international guideline committees including National Comprehensive Cancer Network. Dr Rugo is dedicated to education and mentorship, providing guidance to medical students, residents, and fellows at UCSF and beyond.